T2 Biosystems (LTS:0A57) ROE % Adjusted to Book Value : 0.00% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is T2 Biosystems ROE % Adjusted to Book Value?

T2 Biosystems's ROE % for the quarter that ended in Sep. 2024 was 0.00%. T2 Biosystems's PB Ratio for the quarter that ended in Sep. 2024 was N/A. T2 Biosystems's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

T2 Biosystems ROE % Adjusted to Book Value Historical Data

The historical data trend for T2 Biosystems's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems ROE % Adjusted to Book Value Chart

T2 Biosystems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

T2 Biosystems Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of T2 Biosystems's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, T2 Biosystems's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

T2 Biosystems's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

T2 Biosystems ROE % Adjusted to Book Value Calculation

T2 Biosystems's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

T2 Biosystems's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

T2 Biosystems ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

T2 Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (LTS:0A57) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

TTOO:USA

Address

101 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.t2biosystems.com

T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines